معرفی
M. Lehmann is an active researcher in pulmonary medicine and molecular biology with a strong publication record in high-impact journals including Nature Aging, Cell, EMBO Journal, and American Journal of Respiratory Cell and Molecular Biology. Their research primarily focuses on pulmonary fibrosis mechanisms, precision-cut lung slice technology, DNA methylation, and related molecular signaling pathways.
Lehmann's research interests center on understanding the molecular mechanisms underlying lung diseases, particularly pulmonary fibrosis. Their work has significantly advanced the use of precision-cut lung slices as research tools, providing valuable ex vivo models for studying lung biology and disease progression. The research spans from basic molecular mechanisms to translational applications, with particular emphasis on YAP-TEAD/LOX signaling, immunoproteasome activation, and circadian regulation of lung function.
Analysis of Lehmann's publication history reveals consistent contributions to understanding pulmonary fibrosis mechanisms and developing innovative research methodologies. The work shows increasing focus on molecular signaling pathways in lung disease, with recent publications exploring YAP-TEAD/LOX signaling inhibition as a potential therapeutic approach. Lehmann has also contributed to major collaborative efforts in the field, including the American Thoracic Society Workshop Report on Precision Cut Lung Slices and the COPD-iNET initiative.
Lehmann has established productive collaborations with leading researchers in pulmonary medicine, particularly with Königshoff M, with whom they have co-authored multiple significant publications. These collaborations span institutions and have resulted in high-impact research that bridges basic science and clinical applications in lung disease.
